AU5507999A - Monocyclic compounds having nk-2 antagonist action and compositions containing them - Google Patents

Monocyclic compounds having nk-2 antagonist action and compositions containing them

Info

Publication number
AU5507999A
AU5507999A AU55079/99A AU5507999A AU5507999A AU 5507999 A AU5507999 A AU 5507999A AU 55079/99 A AU55079/99 A AU 55079/99A AU 5507999 A AU5507999 A AU 5507999A AU 5507999 A AU5507999 A AU 5507999A
Authority
AU
Australia
Prior art keywords
compositions containing
antagonist action
monocyclic compounds
monocyclic
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU55079/99A
Inventor
Maria Altamura
Marco Criscuoli
Antonio Dr. Guidi
Carlo Alberto Maggi
Enzo Perrotta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Menarini Ricerche SpA
Original Assignee
Menarini Ricerche SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menarini Ricerche SpA filed Critical Menarini Ricerche SpA
Publication of AU5507999A publication Critical patent/AU5507999A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/22—Tachykinins, e.g. Eledoisins, Substance P; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU55079/99A 1998-08-05 1999-07-30 Monocyclic compounds having nk-2 antagonist action and compositions containing them Abandoned AU5507999A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT1998FI000186A IT1304888B1 (en) 1998-08-05 1998-08-05 MONOCYCLIC ACTION COMPOUNDS NK-2 ANTAGONIST AND FORMULATIONS THAT CONTAIN
ITFI98A0186 1998-08-05
PCT/EP1999/005459 WO2000008046A1 (en) 1998-08-05 1999-07-30 Monocyclic compounds having nk-2 antagonist action and compositions containing them

Publications (1)

Publication Number Publication Date
AU5507999A true AU5507999A (en) 2000-02-28

Family

ID=11352646

Family Applications (1)

Application Number Title Priority Date Filing Date
AU55079/99A Abandoned AU5507999A (en) 1998-08-05 1999-07-30 Monocyclic compounds having nk-2 antagonist action and compositions containing them

Country Status (11)

Country Link
EP (1) EP1102789A1 (en)
JP (1) JP2002522450A (en)
AR (1) AR021751A1 (en)
AU (1) AU5507999A (en)
CA (1) CA2339638A1 (en)
CO (1) CO5080789A1 (en)
IT (1) IT1304888B1 (en)
PE (1) PE20001002A1 (en)
TR (1) TR200100354T2 (en)
TW (1) TW491857B (en)
WO (1) WO2000008046A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1307809B1 (en) 1999-10-21 2001-11-19 Menarini Ricerche Spa BASIC MONOCYCLIC COMPOUNDS WITH NK-2 ANTAGONIST ACTION, MANUFACTURING PROCESSES AND FORMULATIONS CONTAINING THEM.
PT1622569E (en) 2003-04-24 2016-03-03 Incyte Corp Aza spiro alkane derivatives as inhibitors of metallproteases
UY38485A (en) 2018-11-27 2020-06-30 Novartis Ag CYCLIC TETRAMER COMPOUNDS AS PROPROTEIN CONVERTASE SUBTILISIN / KEXIN TYPE 9 (PCSK9) INHIBITORS, METHOD OF TREATMENT, USE AND PREPARATION

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4703034A (en) * 1986-04-28 1987-10-27 Merck & Co., Inc. Novel cyclic tetrapeptide
AU2387592A (en) * 1991-08-08 1993-03-02 A. Menarini Industrie Farmaceutiche Riunite S.R.L. Cyclic hexapeptides as tachyquinin antagonists, their preparation and pharmaceutical compositions thereof
DK0528312T3 (en) * 1991-08-13 1997-12-29 Takeda Chemical Industries Ltd Cyclic peptides and their use
IT1277835B1 (en) * 1995-03-13 1997-11-12 Menarini Farma Ind BICYCLE COMPOUNDS, THEIR PREPARATION AND USE IN PHARMACEUTICAL COMPOSITIONS
IT1291776B1 (en) * 1997-02-07 1999-01-21 Menarini Ricerche Spa MONOCYCLIC COMPOUNDS WITH FOUR BIFUNCTIONAL RESIDUES, HAVING NK-2 ANTAGONIST ACTION

Also Published As

Publication number Publication date
IT1304888B1 (en) 2001-04-05
AR021751A1 (en) 2002-08-07
TR200100354T2 (en) 2001-05-21
TW491857B (en) 2002-06-21
PE20001002A1 (en) 2000-10-16
CA2339638A1 (en) 2000-02-17
EP1102789A1 (en) 2001-05-30
CO5080789A1 (en) 2001-09-25
JP2002522450A (en) 2002-07-23
WO2000008046A1 (en) 2000-02-17
ITFI980186A1 (en) 2000-02-05

Similar Documents

Publication Publication Date Title
GB9917982D0 (en) Compositions
HUP9901606A2 (en) Pharmaceutical compositions comprising sildenaphil
GB9811377D0 (en) Compositions
AU5305899A (en) Powdery pernasal compositions
GB9924268D0 (en) Compositions
HUP0103507A3 (en) Pharmaceutical compositions comprising 2-quinolones
GB9828861D0 (en) Compositions
GB9810529D0 (en) Intumescent composition
GB9803232D0 (en) Compound composition and use
GB9803521D0 (en) New compounds and pharmaceutical compositions thereof
IL138478A0 (en) Paroxetine compositions
AU5507999A (en) Monocyclic compounds having nk-2 antagonist action and compositions containing them
GB2339693B (en) Anti-mollusc compositions
GB9905325D0 (en) Compositions
AP2000001878A0 (en) Pharmaceutical compositions
GB0016470D0 (en) Compositions
GB9806810D0 (en) Compositions
AU5112699A (en) 5-HT1f antagonists
GB2336535B (en) Compositions
GB9827690D0 (en) Compositions
GB9816050D0 (en) Compositions
AU6366399A (en) Compositions containing sucralose and application thereof
GB9821210D0 (en) Polymer compounds and compositions comprising them
AU8869898A (en) Compositions having improved barrier properties
IL142278A0 (en) Imidazo-isoquinoline compounds, their compositions and uses

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase